2009, Volume 16, Issue 02, pages 49-104
EDITORIAL
Br J Cardiol 2009;16:57–9
For patients with established coronary artery disease, lifestyle changes such as dietary modification, smoking cessation, stress management and regular exercise, can help to reduce, or...
Read More
EDITORIAL
Br J Cardiol 2009;16:60–2
In this issue, Pfeffer et al. discuss the impact of anthracycline-related cardiotoxicity and strategies for its treatment and prevention (see pages 85–9). Anthracyclines are not...
Read More
NEWS
Br J Cardiol 2009;16:63-64
The new antiplatelet agent, prasugrel (Lilly/Daiichi Sankyo), has been approved in the European Union for the prevention of atherothrombotic events in patients with acute coronary...
Read More
IN BRIEF
Br J Cardiol 2009;16:63-64
Four different heart-healthy diets showed similar degrees of weight loss in a new study, leading to the conclusion that the type of foods eaten is...
Read More
NEWS
Br J Cardiol 2009;16:63-64
New evidence has been reported suggesting that use of proton pump inhibitors (PPIs) such as omeprazole can reduce the effectiveness of clopidogrel.
In a recent...
Read More
IN BRIEF
Br J Cardiol 2009;16:63-64
There was a 63% increase in the incidence of diabetes in the UK in the ten years between 1996 and 2005, a new study shows.
The...
Read More
IN BRIEF
Br J Cardiol 2009;16:65
News in brief from the world of...
Read More
OBLIQUE VIEW
Br J Cardiol 2009;16:69-71
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this column,...
Read More
CLINICAL ARTICLE
Br J Cardiol 2009;16:73-77
It is well recognised that phase 3 cardiac rehabilitation is beneficial, reducing both mortality and morbidity following acute myocardial infarction. The role of ongoing phase...
Read More
CLINICAL ARTICLE
Br J Cardiol 2009;16:80-84
Chest pain is a common presentation in general practice. Each year about 1% of the UK population visit their GP with chest pain.1 The average...
Read More
CLINICAL ARTICLE
Br J Cardiol 2009;16:85-89
Anthracyclines are commonly used antineoplastic drugs. However, their clinical utility is tempered by a dose-dependent risk of cardiotoxicity and congestive heart failure. Current preventive measures...
Read More
CLINICAL ARTICLE
Br J Cardiol 2009;16:90–7
Co-administered niacin and statin may offer additional lipid management; however, niacin is underutilised due to flushing, mediated primarily by prostaglandin D2 (PGD2). A combination tablet...
Read More
CLINICAL ARTICLE
Br J Cardiol 2009;16:98–101
Heart disease is the leading cause of death in pregnancy. Although women with high-risk cardiac conditions can be identified, the majority of deaths occur without...
Read More
CLINICAL ARTICLE
Br J Cardiol 2009;16:102–4
Angiotensin-receptor blocking drugs have been shown to be an effective therapeutic strategy in a number of cardiovascular diseases. Many randomised controlled trials have demonstrated optimal...
Read More